Showing results (161-170 of 246) with videos related to
Sort By:
Pageof 25
Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2021
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation AnalysisJacob E Berchuck, Sylvan C Baca, Heather M McClure, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cellsMartin K Bakht, John J Hayward, Farsheed Shahbazi-Raz, et al.Nature Communications|July 2, 2025
Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancerKei Mizuno, Sheng-Yu Ku, Varadha Balaji Venkadakrishnan, et al.Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.Cancer Research|December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug developmentDong Lin, Alexander W Wyatt, Hui Xue, et al.Gigascience|May 15, 2018
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implicationsVarune Rohan Ramnarine, Mohammed Alshalalfa, Fan Mo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)Michael J Morris, Glenn Heller, David W Hillman, et al.Scientific Reports|November 7, 2022
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancerFabio Quaglia, Shiv Ram Krishn, Khalid Sossey-Alaoui, et al.JCO Precision Oncology|February 15, 2019
Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials ConsortiumMaria I Carlo, Veda N Giri, Channing J Paller, et al.Pageof 25